about
Selective use of sorafenib in the treatment of thyroid cancerMolecular Targeted Therapies of Aggressive Thyroid CancerVemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trialNew therapies for dedifferentiated papillary thyroid cancerThe discovery and development of sorafenib for the treatment of thyroid cancer.Thyroid dysfunctions induced by tyrosine kinase inhibitors.Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma.Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis toolEfficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials.The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.Personalization of targeted therapy in advanced thyroid cancer.An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma.Sorafenib in the treatment of thyroid cancer.
P2860
Q26752891-048A7F9E-36B6-48A2-B84B-46303B92ED1DQ26774734-C8B86038-AFCB-42A0-8467-2C7579D63C92Q27853396-A055D58F-9ABC-4678-B509-9B21CEB19740Q35381593-EFF36A81-DB09-4BEA-BF78-A4161D325501Q36263304-C7148B07-FB5F-4306-A303-3191E96C54BCQ38211342-CE475F32-4BD9-4381-B612-BF113C4880E6Q38368008-FE5AE43C-A08C-4CDC-A3A4-ED5A400FE927Q38611037-1A8C5818-39CA-4E4F-92B0-B1DE4A5A3399Q38791974-DA72CFC4-140B-4E4D-8DE4-B9DBDA190088Q38960074-AA23EF41-8480-4639-9181-235CBB7A8D2FQ40922523-ED4B8B87-683A-40F2-BA38-84BE7100A5ABQ44116793-959FFB5A-443F-410A-9F36-B409E7FEFCE0Q55053748-31388F75-F2AA-4A7A-B759-46E4A3CC2934
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sorafenib and thyroid cancer.
@en
type
label
Sorafenib and thyroid cancer.
@en
prefLabel
Sorafenib and thyroid cancer.
@en
P2093
P2860
P1433
P1476
Sorafenib and thyroid cancer.
@en
P2093
Alda Corrado
Alessandro Antonelli
Francesca Santini
Gabriele Materazzi
Paolo Miccoli
Poupak Fallahi
Salvatore Ulisse
Silvia Martina Ferrari
P2860
P2888
P304
P356
10.1007/S40259-013-0049-Y
P577
2013-12-01T00:00:00Z